Bài kiểm tra có liên kết hướng dẫn · Trung bình Cấp độ

AI trong bài kiểm tra siêu âm nốt tuyến giáp

Kiểm tra tính năng chấm điểm siêu âm, ACR TI-RADS, kích thước nốt sần, quyết định sinh thiết và xác nhận bên ngoài của AI tuyến giáp. Nó cũng ghi nhận sự xem xét của người lớn.

Đường dẫn hướng dẫn liên quanAI trong siêu âm nhân tuyến giáp
Câu hỏi 1 của 8

Which ultrasound features are scored in the ACR TI-RADS framework?

Xem trước mọi câu hỏi8 câu hỏi

Câu trả lời và giải thích xuất hiện khi bạn làm bài kiểm tra.

  1. Which ultrasound features are scored in the ACR TI-RADS framework?
    • Serum TSH, family history and prior radiation exposure
    • Nodule growth rate, patient age and compressive symptoms
    • Composition, echogenicity, shape, margins and echogenic foci
    • Blood count, urine protein and serum creatinine
  2. What can an AI thyroid-ultrasound tool help with?
    • Confirming cancer without any clinical review
    • Choosing treatment based only on an image
    • Replacing the ultrasound examination
    • Detecting or outlining nodules and assisting with image-feature scoring
  3. What factors help determine whether a nodule is followed or biopsied?
    • Risk category together with nodule size and clinical context
    • The model’s confidence score regardless of nodule size
    • One suspicious feature without considering the whole ultrasound
    • The number of images in the report
  4. Why may a model trained on one ultrasound dataset fail to transfer?
    • The thyroid is never visible on ultrasound
    • Machines, image quality, operators and populations can differ
    • All nodules have identical appearances
    • Risk categories do not use images
  5. What would provide stronger evidence that AI reduces unnecessary FNA biopsies?
    • A retrospective image-accuracy score only
    • A vendor statement that the tool saves time
    • A prospective study measuring biopsy decisions and patient outcomes
    • A model’s agreement with its own training labels
  6. Which consequence could follow a false-negative AI suggestion?
    • A benign nodule could be sent for unnecessary biopsy
    • A false-positive label could add follow-up imaging
    • An image file could require a different storage format
    • A nodule needing assessment could receive delayed follow-up
  7. Does accurate nodule segmentation alone validate a biopsy recommendation?
    • No; locating a nodule differs from classifying risk and recommending management
    • Yes, if the outline matches a radiologist’s boundary
    • Yes, because segmentation removes reader differences
    • No, because ultrasound cannot show thyroid nodules
  8. Who remains responsible for the final report and management plan?
    • The image model alone
    • The radiologist and treating clinician
    • The ultrasound manufacturer
    • The patient portal